In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
BioMatrix Infusion Pharmacy has acquired First Choice Wellness Centers, a regional leader in ambulatory infusion services. The company says the deal marks another significant ...
By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...
BioMatrix acquired First Choice Wellness Centers to strengthen access to patient-focused, convenient, and clinically coordinated infusion therapy throughout key markets in the Southeast. First Choice ...
A phase 3 study shows tafasitamab combined with lenalidomide and R-CHOP significantly improves outcomes for untreated DLBCL patients.
Zacks Investment Research on MSN
INCY's phase III Monjuvi study meets key goals in first-line lymphoma
Incyte INCY announced positive top-line results from a late-stage lymphoma study of Monjuvi/Minjuvi (tafasitamab), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback